onr:"swepub:oai:DiVA.org:liu-173466"
Search: onr:"swepub:oai:DiVA.org:liu-173466" > Portal vein emboliz...
- 1 of 1
- Previous record
- Next record
- To hitlist
Portal vein embolization with N-butyl cyanoacrylate glue is superior to other materials : a systematic review and meta-analysis
-
- Ali, Adnan (author)
- Univ Lancaster, England
-
- Ahle, Margareta (author)
- Linköpings universitet,Medicinska fakulteten,Institutionen för hälsa, medicin och vård,Region Östergötland, Röntgenkliniken i Linköping
-
- Björnsson, Bergthor (author)
- Linköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Kirurgiska kliniken US
- show more...
- show less...
- (creator_code:org_t)
- 2021-01-26
- 2021
- English.
- In: European Radiology. - : Springer. - 0938-7994 .- 1432-1084. ; 31:8, s. 5464-5478
- Research review (peer-reviewed)
Abstract
Subject headings
Close
- Objectives It remains uncertain which embolization material is best for portal vein embolization (PVE). We investigated the various materials for effectiveness in inducing future liver remnant (FLR) hypertrophy, technical and growth success rates, and complication and resection rates. Methods A systematic review from 1998 to 2019 on embolization materials for PVE was performed on Pubmed, Embase, and Cochrane. FLR growth between the two most commonly used materials was compared in a random effects meta-analysis. In a separate analysis using local data (n = 52), n-butyl cyanoacrylate (NBCA) was compared with microparticles regarding costs, radiation dose, and procedure time. Results In total, 2896 patients, 61.0 +/- 4.0 years of age and 65% male, from 51 papers were included in the analysis. In 61% of the patients, either NBCA or microparticles were used for embolization. The remaining were treated with ethanol, gelfoam, or sclerosing agents. The FLR growth with NBCA was 49.1% +/- 29.7 compared to 42.2% +/- 40 with microparticles (p = 0.037). The growth success rate with NBCA vs microparticles was 95.3% vs 90.7% respectively (p < 0.001). There were no differences in major complications between NBCA and microparticles. In the local analysis, NBCA (n = 41) entailed shorter procedure time and reduced fluoroscopy time (p < 0.001), lower radiation exposure (p < 0.01), and lower material costs (p < 0.0001) than microparticles (n = 11). Conclusion PVE with NBCA seems to be the best choice when combining growth of the FLR, procedure time, radiation exposure, and costs.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)
Keyword
- Portal vein; Embolization; therapeutic; Enbucrilate; Hypertrophy; Radiation dosage
Publication and Content Type
- ref (subject category)
- for (subject category)
Find in a library
- European Radiology (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Ali, Adnan
- Ahle, Margareta
- Björnsson, Bergt ...
- Sandström, Per
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Radiology Nuclea ...
- Articles in the publication
- European Radiolo ...
- By the university
- Linköping University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
